NCT07454668 2026-03-06
Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases
Baptist Health South Florida
Phase 1 Not yet recruiting
Clinical Trials
9 trialsNCT03807765 2025-12-04
Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT02685332 2025-07-20
Phase I Dose Escalation of Single Fraction Adjuvant Stereotactic Body Partial Breast Irradiation Early Stage Breast CA
University of Texas Southwestern Medical Center
Phase 1 Active not recruiting
NCT06130826 2025-05-30
Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer
City of Hope Medical Center
Phase 1 Recruiting
NCT00944528 2023-10-27
RSU
Duke University
Phase 1 Completed
NCT02206334 2022-05-25
Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer
NRG Oncology
Phase 1 Completed
NCT01162200 2020-08-20
Cyberknife® Partial Breast Irradiation (PBI) for Early Stage Breast Cancer
University of Texas Southwestern Medical Center
Phase 1 Completed
NCT03151447 2017-05-12
Stereotactic Body Radiation Therapy Combined With Anti-PD-1 Antibody in Metastatic Triple Negative Breast Cancer
Fudan University
Phase 1 Unknown
NCT02065960 2015-03-31
ARTEMIS
Juravinski Cancer Center
Phase 1 Unknown